Find a Doctor

Sanjay Ahuja, MD

Sanjay Ahuja, MD


Pediatric Hematology and Oncology

Accepting New Patients

Primary Location

UH Rainbow Babies and Children's Hospital
11100 Euclid Ave
Cleveland, OH 44106

Schedule an Appointment



  • Medical Director, Pediatric Hematology/Oncology, UH Rainbow Babies and Children's Hospital
  • Director, Hemophilia Program, UH Cleveland Medical Center
  • Medical Director, Pediatric Hematology/Oncology, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine


  • Bleeding Disorders
  • Pediatric Hematology
  • Pediatric Hemostasis
  • Thrombocytopenias
  • Thrombotic Disorders


Watch to find out more about this University Hospitals provider.

Languages Spoken

English, Hindi

Office Locations

UH Rainbow Babies and Children's Hospital

11100 Euclid Ave
Cleveland, OH 44106

UH Solon Health Center

34055 Solon Rd
Solon, OH 44139

UH North Ridgeville Health Center

32800 Lorain Rd
North Ridgeville, OH 44039

Certifications & Memberships

  • Pediatric Hematology-Oncology - American Board of Pediatrics


Other Education
University Of Pittsburgh School Of Medicine (2002 - 2004)

Fellowship | Pediatric Hematology/Oncology
Pediatric Hematology/Oncology - Children's Hospital Of Pittsburgh Of Upmc (2001 - 2004)

Residency | Pediatrics
Pediatrics - Lincoln Medical And Mental Health Center (1999 - 2001)

Internship | Pediatrics
Pediatrics - Lincoln Medical And Mental Health Center (1998 - 1999)

Medical Education
Seth Gs Medical College, Maharashtra University Of Health Sciences (1993)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Sanjay Ahuja disclosed the following Outside Relationships with Industry:

  • - Baxalta - Honoraria
  • - Biogen Idec - Honoraria
  • - Dynavax Technologies - Ownership
  • - Adaptimmune Therapeutics - Ownership